Bay Street News, January, 2019

Dr. Ralph Kern to Provide Update on the Phase 3 Pivotal Trial of Autologous MSC-NTF Cellular Therapy (NurOwn®) in ALS […]

VANCOUVER, British Columbia, Jan. 10, 2019 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to […]

Aurora, IL, Jan. 10, 2019 (GLOBE NEWSWIRE) — Cabot Microelectronics Corporation (Nasdaq: CCMP), a leading global supplier of consumable materials […]

ANTIGONISH, Nouvelle-Écosse, 11 janv. 2019 (GLOBE NEWSWIRE) — Biome Grow Inc. (« Biome » ou la « Société ») (CSE […]

ANTIGONISH, Nova Scotia (Kanada), Jan. 11, 2019 (GLOBE NEWSWIRE) — Biome Grow Inc. („Biome“ oder das „Unternehmen“) (CSE: BIO) (Frankfurt: […]

Revenue increased by 16.3% (14.2% in constant currency(1)), to reach $643.3 million; Adjusted EBITDA(1) increased by 15.7% (13.8% in constant […]

Increases Common Share Dividend for the 26TH Consecutive Year CALGARY, Alberta, Jan. 10, 2019 (GLOBE NEWSWIRE) — The Board of […]

CALGARY, Alberta, Jan. 10, 2019 (GLOBE NEWSWIRE) — (TSX: CIU.PR.A, CIU.PR.C)   The Board of Directors of CU Inc. has declared […]

Increases Common Share Dividend for the 47th consecutive year and announces suspension of the Dividend Reinvestment Program CALGARY, Alberta, Jan. […]

Revenue increased by 15.1% (13.1% in constant currency(1)), to reach $674.0 million; Adjusted EBITDA(1) increased by 15.0% (13.1% in constant […]